Načítá se...
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus
Antibiotic resistance is a worldwide problem that needs to be addressed. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the dangerous “ESKAPE” pathogens that rapidly evolve and evade many current FDA-approved antibiotics. Thus, there is an urgent need for new anti-MRSA compounds. Ebsel...
Uloženo v:
| Vydáno v: | Bioorg Med Chem |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045767/ https://ncbi.nlm.nih.gov/pubmed/27073054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.03.060 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|